Your browser doesn't support javascript.
loading
Long-term survival of NPM1 AML treated with intensive chemotherapy with extensive molecular data available.
Garciaz, Sylvain; Berton, Guillaume; Hospital, Marie-Anne; Guille, Arnaud; Adélaïde, José; Saillard, Colombe; Hicheri, Yosr; Mozziconacci, Marie-Joëlle; Duprez, Estelle; Récher, Christian; Alary, Anne-Sophie; Birnbaum, Daniel; Vey, Norbert.
Affiliation
  • Garciaz S; Department of Hematology, Institut Paoli-Calmettes, INSERM UMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France.
  • Berton G; Department of Hematology, Institut Paoli-Calmettes, INSERM UMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France.
  • Hospital MA; Department of Hematology, Institut Paoli-Calmettes, INSERM UMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France.
  • Guille A; Predictive Oncology Laboratory, Marseille Cancer Research Center, INSERMUMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France.
  • Adélaïde J; Predictive Oncology Laboratory, Marseille Cancer Research Center, INSERMUMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France.
  • Saillard C; Department of Hematology, Institut Paoli-Calmettes, INSERM UMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France.
  • Hicheri Y; Department of Hematology, Institut Paoli-Calmettes, INSERM UMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France.
  • Mozziconacci MJ; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France.
  • Duprez E; Epigenetic Factors in Normal and Malignant Hematopoiesis, Marseille Cancer Research Center, INSERMUMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France.
  • Récher C; Department of Hematology, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.
  • Alary AS; Université Toulouse III Paul Sabatier, Cancer Research Center of Toulouse, UMR1037-INSERM, ERL5294 CNRS, Toulouse, France.
  • Birnbaum D; Department of Cancer Biology, Institut Paoli-Calmettes, Marseille, France.
  • Vey N; Predictive Oncology Laboratory, Marseille Cancer Research Center, INSERMUMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France.
Leuk Lymphoma ; 65(5): 700-703, 2024 May.
Article in En | MEDLINE | ID: mdl-38329727
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nuclear Proteins / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Nucleophosmin Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Francia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nuclear Proteins / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Nucleophosmin Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Francia